James E. Udelson

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 16 papers. Top paper: “Comparison of an Initial Risk-Based Testing Strategy vs Usual Testing in Stable Symptomatic Patients With Suspected Coronary Artery Disease”.

Comparison of an Initial Risk-Based Testing Strategy vs Usual Testing in Stable Symptomatic Patients With Suspected Coronary Artery Disease

JAMA Cardiology(2023)10.1001/jamacardio.2023.2595

N/A

2.1DataRank · unranked

97 citations

Michael G. Nanna, Michelle D. Kelsey, Eric Yow, Daniel B. Mark, Manesh R. Patel +95 more

Discordance of High-Sensitivity Troponin Assays in Patients With Suspected Acute Coronary Syndromes

Journal of the American College of Cardiology(2021)10.1016/j.jacc.2021.01.046

N/A

1.9DataRank · unranked

34 citations

Thomas Mayrhofer, Maros Ferencik, John T. Nagurney, James E. Udelson, Andreas A. Kammerlander +6 more

Vericiguat in patients with chronic heart failure and reduced ejection fraction (VICTOR): a double-blind, placebo-controlled, randomised, phase 3 trial

The Lancet(2025)10.1016/s0140-6736(25)01665-4

N/A

1.3DataRank · unranked

71 citations

Ciaran J. McMullan, Kevin J. Anstrom, Irina Barash, Marc P. Bonaca, Maria Borentain +94 more

Vericiguat for patients with heart failure and reduced ejection fraction across the risk spectrum: an individual participant data analysis of the VICTORIA and VICTOR trials

The Lancet(2025)10.1016/s0140-6736(25)01682-4

N/A

0.550DataRank · unranked

38 citations

Christopher M. O’Connor, Javed Butler, Ciaran J. McMullan, Kevin J. Anstrom, Irina Barash +84 more

Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of CRD-740, a PDE9 Inhibitor, in Chronic Heart Failure

JACC Heart Failure(2025)10.1016/j.jchf.2025.102706

N/A

0.208DataRank · unranked

3 citations

Jan Bělohlávek, Andrej Dukát, Justin A. Ezekowitz, Sorel Goland, Béla Merkely +14 more

Agreement among high-sensitivity cardiac troponin assays and non-invasive testing, clinical outcomes, and quality-of-care outcomes based on the 2020 European Society of Cardiology Guidelines

European Heart Journal Acute Cardiovascular Care(2023)10.1093/ehjacc/zuad146

N/A

0.104DataRank · unranked

1 citations

Thomas Mayrhofer, James L. Januzzi, James E. Udelson, Jerome L. Fleg, Béla Merkely +7 more

Soluble guanylate cyclase stimulators in patients with heart failure with reduced ejection fraction across the risk spectrum

European Journal of Heart Failure(2022)10.1002/ejhf.2720

N/A

0DataRank · unranked

36 citations

Muhammad Usman, Kevin J. Anstrom, Robert O. Blaustein, Marc P. Bonaca, Justin A. Ezekowitz +14 more

Clinical and cost implications of deferred testing in low-risk patients with stable chest pain: a simulation using the PROMISE trial

American Heart Journal(2023)10.1016/j.ahj.2023.02.010

N/A

0DataRank · unranked

3 citations

Eric Yow, Sreekanth Vemulapalli, Daniel B. Mark, Michelle D. Kelsey, Manesh R. Patel +5 more

Chronic Conditions and Patient-Centered Outcomes After Transcatheter Aortic Valve Intervention

JACC Advances(2025)10.1016/j.jacadv.2025.102231

N/A

0DataRank · unranked

0 citations

Amanda Stebbins, Mohamad Alkhouli, Dharam J. Kumbhani, Tsuyoshi Kaneko, Vinod Thourani +12 more

Invasive Hemodynamic Assessment and Classification of In-Hospital Mortality Risk Among Patients With Cardiogenic Shock

Circulation Heart Failure(2020)10.1161/circheartfailure.120.007099

N/A

0DataRank · unranked

305 citations

Elric Zweck, Mohyee Ayouty, A.R. Garan, Jaime Hernández-Montfort, Claudius Mahr +16 more

Diagnosis and Risk Stratification in Acute Coronary Syndromes

Atlas of Nuclear Cardiology(2021)10.1007/978-3-030-49885-6_12

N/A

0DataRank · unranked

0 citations

Carlos D. Davila, James E. Udelson

Effects of Elamipretide on Left Ventricular Function in Patients With Heart Failure With Reduced Ejection Fraction: The PROGRESS-HF Phase 2 Trial

Journal of Cardiac Failure(2020)10.1016/j.cardfail.2020.02.001

N/A

0DataRank · unranked

102 citations

Muhammad Shahzeb Khan, Stefan D. Anker, Gregg C. Fonarow, Raymond J. Kim, Savina Nodari +11 more

Acute Kidney Function Declines in the Context of Decongestion in Acute Decompensated Heart Failure

JACC Heart Failure(2020)10.1016/j.jchf.2020.03.009

N/A

0DataRank · unranked

86 citations

Hocine Tighiouart, Jeffrey M. Testani, Matthew D. Griffin, Marvin A. Konstam, James E. Udelson +2 more

Cost-effectiveness Analysis of Anatomic vs Functional Index Testing in Patients With Low-Risk Stable Chest Pain

JAMA Network Open(2020)10.1001/jamanetworkopen.2020.28312

N/A

0DataRank · unranked

59 citations

Thomas Mayrhofer, Alexander Ivanov, Borek Foldyna, Michael T. Lu, Maros Ferencik +7 more

Can Clinical Predictive Models Identify Patients Who Should Not Receive TAVR? A Systematic Review

Structural Heart(2020)10.1080/24748706.2020.1782549

N/A

0DataRank · unranked

8 citations

Andrew Weintraub, James E. Udelson, David M. Kent, Benjamin S. Wessler

Time Delay, Infarct Size, and Microvascular Obstruction After Primary Percutaneous Coronary Intervention for ST-Segment–Elevation Myocardial Infarction

Circulation Cardiovascular Interventions(2021)10.1161/circinterventions.120.009879

N/A

0DataRank · unranked

71 citations

Reza Mohebi, Gennaro Giustino, Shmuel Chen, Harry P. Selker, Holger Thiele +10 more